Soleno Therapeutics Inc (SLNO) operating margin is 33.6%
Soleno Therapeutics Inc (SLNO) operating margin is 33.6%. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full SLNO research page for quote, filings, and the rest of the model. This satellite exists so “Soleno Therapeutics Inc operating margin” can rank with the actual number, then send you to /stock/slno.